Although not formally proven, it is likely that the elevated serum levels of CXCL13 found in patients with IPAH and CTEPH result from a spillover of CXCL13 overexpressed in the lungs. The gene discussed is CXCL13; the disease is chronic thromboembolic pulmonary hypertension.